Pharmaceutical Industry

Page 15 of 100

“Even though health insurance costs are the second-largest line item after payroll, CEOs don’t really understand it or know anything about it,” billionaire entrepreneur and Shark Tank investor Mark Cuban tells Fortune’s Lindsey Leake.
Health

Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big

By
March 8, 2024
Photo of Bill Anderson
Health

Bayer CEO compares the state of troubled pharma group to the time he fractured his leg skateboarding: ‘We’re badly broken in 4 places’

By
March 6, 2024
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.
Retail

Novo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says

By Niclas Rolander and Bloomberg
March 5, 2024
The Mark Cuban Cost Plus Drug Company will begin manufacturing its own medications in Dallas this week, cofounder and CEO Dr. Alex Oshmyansky announced Monday, March 4, 2024.
Health

Mark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week

By
March 5, 2024
First over-the-counter birth control pill in U.S. begins shipping to stores
Health

First over-the-counter birth control pill in U.S. begins shipping to stores

By Matthew Perrone and The Associated Press
March 4, 2024
Stock traders from various companies work in five circular and one semi-circular trading floor at the Frankfurt Stock Exchange.
Finance

Meet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy

By
March 3, 2024
BOXES OF WEGOVY DRUGS
Lifestyle

Novo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results

By
February 27, 2024
People sit and enjoy drinks in the sunshine at Nyhavn, a waterfront, canal and entertainment district in Copenhagen, Denmark
Newsletters

Denmark, home to Ozempic-maker Novo Nordisk, is now Europe’s third-most prosperous economy

By Peter Vanham and Nicholas Gordon
February 27, 2024
Sanofi CEO: AI promises a great era of drug discovery that could fundamentally change medicine–but only if we allow it to deliver
Commentary

Sanofi CEO: AI promises a great era of drug discovery that could fundamentally change medicine–but only if we allow it to deliver

By
February 19, 2024
Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers

Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers

By Arthur Allen and KFF Health News
February 16, 2024
Jill Feldman, 54, poses for a photo at her home in Deerfield, Ill., on Jan. 19. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by blocking a signal that tells cancer cells to grow.
Health

As cancer treatment advances, advocates push back against ‘maximum tolerated dose,’ citing patient suffering

By Carla K. Johnson and The Associated Press
February 6, 2024
Patients given a monthly injection of Amgen’s drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according to a small, early-stage study published Monday in the journal Nature Metabolism.
Health

Experimental once-a-month weight loss injectable shows lasting results in early study

By Madison Muller and Bloomberg
February 5, 2024
U.S. drug price negotiations are underway. Here’s what that will mean for you—eventually

U.S. drug price negotiations are underway. Here’s what that will mean for you—eventually

By
February 2, 2024
The last time there was this much hype over a new drug was for Viagra, which was approved in 1998. Yet hurdles remain, when it comes to the ability of patients to access weight loss and anti-diabetes injectables like Zepbound and Wegovy: These drugs cost a lot, insurance coverage is spotty, and patients may need to take them indefinitely to avoid regaining weight.
Health

Weight-loss injectables like Zepbound are making as big of a splash as Viagra, if not bigger. What you need to know about the ‘miracle drugs’

By Emma Court, Madison Muller and Bloomberg
January 31, 2024
‘We are using all the tools we have’: Lina Khan’s FTC takes aim at Big Pharma’s ‘patent thickets’, arguing they keep old drugs too pricey
Politics

‘We are using all the tools we have’: Lina Khan’s FTC takes aim at Big Pharma’s ‘patent thickets’, arguing they keep old drugs too pricey

By Elisabeth Rosenthal and KFF Health News
January 31, 2024

Most Popular